Fibrosis occurs when inflammation activates immune cells and fibroblasts to release collagen and cytokines that remodel and ...

“The results of our analysis showed that overall, patients with SCLC who survived to receive 3L treatment are a select group with exceptionally long 1L OS of 24.5 versus 14.9 months for ...

Glucagon-like peptide 1 receptor agonists (GLP-1RA) have made waves as treatments for obesity and type 2 diabetes, but a new report suggests they might also have clinical benefits for certain patients ...

Midlife weight gain is a persistent challenge for many women, but emerging research suggests hormone therapy may enhance response to glucagon-like peptide-1 (GLP-1)–based treatments.

AMCP Nexus 2025 will focus on drug pricing, access, and reimbursement, influenced by the Inflation Reduction Act and One Big ...

Multigene next-generation sequencing (NGS) performed directly on tumor tissue can accurately identify pathogenic variants in epithelial ovarian cancer (EOC), detecting both somatic and germline ...

US safety data show that elinzanetant caused few adverse events and no new liver-related concerns in women, James Simon, MD, explains. Nonhormonal treatment options for vasomotor symptoms continue to ...

Extreme temperatures were found to exacerbate cardiovascular mortality in older patients with heart failure (HF), according to a new research letter published in JAMA Cardiology. 1 As human biology ...

Breast cancer is the most-researched disease, yet only 14% of trials reach optimal enrollment, highlighting a significant gap in clinical trial participation. COVID-19 has increased trial attrition ...

The FDA has approved revumenib (Revuforj; Syndax Pharmaceuticals) for patients aged 1 year and older with relapsed or ...

Liver Awareness Month, observed each October, increases public understanding of the causes, symptoms, and outcomes of liver disease and highlights steps that can be taken at both the individual and ...